Geode Capital Management
EVFM

Geode Capital Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Geode Capital Management’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-97,953
Closed -$110K – 5110
2022
Q2 		$110K Sell
97,953
-3,471
-3% -$5.72K ﹤0.01% 4557
2022
Q1 		$517K Buy
101,424
+10,615
+12% +$66.8K ﹤0.01% 3918
2021
Q4 		$511K Buy
90,809
+1,309
+1% +$11.1K ﹤0.01% 4032
2021
Q3 		$991K Buy
89,500
+12,114
+16% +$152K ﹤0.01% 3683
2021
Q2 		$1.31M Sell
77,386
-10,737
-12% -$204K ﹤0.01% 3465
2021
Q1 		$2.31M Buy
88,123
+5,398
+7% +$245K ﹤0.01% 3189
2020
Q4 		$2.99M Buy
82,725
+12,000
+17% +$434K ﹤0.01% 2869
2020
Q3 		$2.5M Buy
70,725
+34,971
+98% +$1.52M ﹤0.01% 2764
2020
Q2 		$1.52M Buy
35,754
+18,076
+102% +$1.22M ﹤0.01% 2991
2020
Q1 		$1.41M Buy
17,678
+303
+2% +$24.2K ﹤0.01% 2859
2019
Q4 		$1.61M Sell
17,375
-1,462
-8% -$123K ﹤0.01% 3101
2019
Q3 		$1.42M Buy
18,837
+11
+0.1% +$845 ﹤0.01% 3101
2019
Q2 		$1.88M Buy
18,826
+13,863
+279% +$1.07M ﹤0.01% 2995
2019
Q1 		$260K Buy
4,963
+53
+1% +$2.87K ﹤0.01% 3658
2018
Q4 		$308K Buy
4,910
+2,628
+115% +$145K ﹤0.01% 3544
2018
Q3 		$138K Buy
+2,282
New +$98.8K ﹤0.01% 3863
2017
Q4 		– Sell
-382
Closed -$15K – 4048
2017
Q3 		$15K Hold
382
– – ﹤0.01% 4026
2017
Q2 		$18K Sell
382
-22
-5% -$3.85K ﹤0.01% 4049
2017
Q1 		$58K Buy
404
+3
+0.7% +$389 ﹤0.01% 3926
2016
Q4 		$40K Buy
401
+2
+0.5% +$208 ﹤0.01% 3942
2016
Q3 		$40K Hold
399
– – ﹤0.01% 3937
2016
Q2 		$35K Hold
399
– – ﹤0.01% 3976
2016
Q1 		$21 Hold
399
– – ﹤0.01% 4052
2015
Q4 		$49K Buy
399
+1
+0.3% +$659 ﹤0.01% 4009
2015
Q3 		$289K Buy
398
+219
+122% +$235K ﹤0.01% 3510
2015
Q2 		$145K Hold
179
– – ﹤0.01% 3676
2015
Q1 		$132K Buy
+179
New +$114K ﹤0.01% 3698

Other funds holding EVFM

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Geode Capital Management's EVFM Position: Q3 2022 in Review

Geode Capital Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 97,953 shares — an estimated $110K sold.

Geode Capital Management first reported a position in EVFM in Q1 2015 and held it in 27 quarters. The position peaked at $2.99M in Q4 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

  • Geode Capital Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Geode Capital Management sold 97,953 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $110K.
  • Geode Capital Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2015 and held it in 27 quarters.
  • Geode Capital Management's Evofem Biosciences, Inc. Common Stock position peaked at $2.99M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Geode Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.